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Abstract
Cell culture is one of the most important and commonly used in vitro tools to 
comprehend various aspects of cells or tissues of a living body such as cell biology, 
tissue morphology, mechanism of diseases, cell signaling, drug action, cancer 
research and also finds its great importance in preclinical trials of various drugs. 
There are two major types of cell cultures that are most commonly used- two-
dimensional (2D) and three-dimensional culture (3D). The former has been used 
since the 1900s, owing to its simplicity and low-cost maintenance as it forms a 
monolayer, while the latter being the advanced version and currently most worked 
upon. This chapter intends to provide the true meaning and significance to both 
cultures. It starts by making a clear distinction between the two and proceeds 
further to discuss their different applications in vitro. The significance of 2D culture 
is projected through different assays and therapeutic treatment to understand cell 
motility and treatment of diseases, whereas 3D culture includes different models 
and spheroid structures consisting of multiple layers of cells, and puts a light on its 
use in drug discovery and development. The chapter is concluded with a detailed 
account of the production of therapeutic proteins by the use of cells.
Keywords: Cell culture, 2D culture, 3D culture, drug action, therapeutics
1. Introduction
The growth of cells in a controlled artificial environment isolated from their 
natural habitat is referred to as cell culture [1]. It is a significant tool used widely to 
study cell and molecular biology, screening drugs and toxicity analysis, the role of 
a particular gene in a disease, and cancer research. Due to their unique properties, 
they also have been tuned for screening and developing biopharmaceutical com-
pounds such as vaccines and recombinant proteins. One of the major advantages of 
using cell culture is the homogenous and reproducible data generated [2].
Drug discovery is a lengthy and time-consuming process that undergoes several 
stages of testing and optimization. This encompasses identification of the target, 
lead discovery, pre-clinical validation, and clinical trials [3]. Therefore, it is very 
pertinent to obtain information about the biological activity, biochemical mecha-
nisms, toxicity, and off-target interactions of drug molecules leading to the early 
stages of drug discovery. In vitro, cell-based assays prove futile to understand the 
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effects of drugs on the cells at an early stage of drug discovery which attributes an 
increased chance of development of drugs with good efficacy and safety [4].
Two-dimensional (2D) cell culture was introduced many decades ago that has 
been the major type of cell culture technique in numerous fields. This traditional 
approach has been extensively used for drug screening due to its relatively inex-
pensive feature and convenience to use. However, the issue of mimicking the in 
vivo environment restricts its use [5]. The 2D cell cultures grow as a monolayer in 
controlled flat environments, such as a glass or polystyrene flask that comprises 
live proliferating cells because of the detachment of dead cells from the surface 
(Figure 1). As a result, this leads to uniformity in nutrients and growth factors 
present in the medium to which the cells get access and proliferate at a faster 
rate than they would in vivo [6]. Thus, the morphology of the cells is completely 
changed as they appear flattered and stretched as compared to the in vivo environ-
ment. Besides this, the cell–cell interactions and cell-extracellular interactions 
become different in comparison to the tumor [7].
Recently there has been an upsurge of interest towards three-dimensional (3D) 
cell culture in biomedical research and drug development processes due to its high-
throughput accuracy and refined in vitro models [8]. They have been broadly used in 
understanding the cell shape, cell–cell interaction, and the cellular environment that 
efficiently mimics the in vivo environment. 3D cultures grow as clusters or aggregates 
called spheroids either with a matrix or without a matrix [9] (Figure 1). There is a 
gradient of nutrients across these spheroids due to which the cells at the surface of 
spheroids proliferate more as compared to the cells that are present in the interior 
[10]. As a result of the difference in the proliferation rate, the cells in the spheroids are 
usually in different stages of the cell cycle such as proliferating, quiescent, hypoxic, 
and necrotic cells. In the 3D culture, the cells have uniform access to nutrients as 
in the case of a tumor. Also, the shape of the cells, cell–cell interactions, and cell-
environment interactions are well defined in 3D culture [7]. It has also been observed 
that 2D cell cultures are more sensitive to drugs as compared to 3D cells [11]. This 
chapter intends to provide the true meaning and significance of both cultures. It starts 
by making a clear distinction between the two and proceeds further to discuss their 
Figure 1. 
Simplified sketch of 2D cell culture (a) and 3D cell culture (b).
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different applications in vitro. The significance of 2D culture is projected through 
different assays and therapeutic treatment to understand cell motility and treatment 
of diseases, while 3D culture includes different models and spheroid structures 
consisting of multiple layers of cells, and puts a light on its use in drug discovery and 
development. The chapter is concluded with a detailed account of the production of 
therapeutic proteins by the use of cells.
2. In vitro applications of 2D culture
2.1 In vitro cytotoxicity assays and tissue-engineered tissue models
Cytotoxicity assays are commonly used for in vitro toxicology and pharmacology 
studies for the screening the effect of chemicals and drugs on the cultured cells. There 
are different assays available for measuring cytotoxicity namely- the colony-forming 
assay and dye inclusion or exclusion such as neutral red and trypan blue assay is the 
most significantly used. Cytotoxicity assays can be broadly divided into the follow-
ing categories– (i) Assays based on metabolism, (ii) Adenosine triphosphate (ATP) 
Bioluminescence Assay and (iii) Assays based on the release of enzymes.
Assays based on metabolism generally include the 3-(4,5-dimethythiazol2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and its alternatives such as 
2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide 
(XTT),3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium(MTS) and sulforhodamine B (SRB) assay. Due to 
rapid, quantitative, versatile, and highly reproducibility of MTT, it is widely used in 
large-scale, anti-tumor drug-screening program. MTT is a quantitative colorimetric 
assay that quantifies the reduction of yellow tetrazolium dye by mitochondrial 
succinate dehydrogenase to purple insoluble formazan crystals by the NADPH 
dependent cellular oxidoreductase enzymes [12]. The crystals are dissolved in an 
appropriate solvent. The absorbance is then recorded using a spectrophotometer to 
analyze the cell viability wherein the crystals get accumulated in the viable cells due 
to their impermeability to the cell membrane.
ATP Bioluminescence Assay is used to measure the ATP level that is well regu-
lated in the metabolically active live eukaryotic cells as compared to the dead cells 
wherein the ATP level falls due to the activity of ATPases. This assay includes a 
luciferase enzyme that utilizes energy from ATP that converts luciferin into oxylu-
ciferin and thus produces luminescence. Therefore, luminescence could be used to 
measure the ATP level. Assays based on the release of enzymes are more significant 
as they measure the products released by the dead cells [13].
Assays based on the release of enzymes include Lactate dehydrogenase(LDH) 
leakage assay involving the formation of pyruvate from lactate in the presence of 
LDH with simultaneous reduction of NAD to NADH that alters the absorbance at 
340 nm [14]. Research in cancer and cell biology is greatly dependent on in vitro 
assays and models. This help in understanding the various responses of the cultured 
cells when exposed to different conditions. Tissue-engineered in vitro tissue models 
serve as an alternative to in vivo animal studies to study the physiology of various 
diseases. Example of tissue-engineered in vitro models includes Skeletal Muscle 
Models [15], blood–brain barrier model [16], aneurysm models [17] and the Pre-
vascularized Human Vaginal Mucosa model [18].
2.2 Cell migration assay
Cell migration is well known for its significant role in embryonic morphogen-
esis, cancer invasion and metastasis, immune responses, tissue formation, and 
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angiogenesis [19]. Mainly, cell migration is of two types; single-cell migration and 
collective cell migration. Single-cell migration is regulated by cytoskeletal activity 
without cell-to-cell interactions with neighboring cells. This type of migration is 
important for embryonic development, immune response, and in the early stages 
of metastasis. On the other hand in the collective cell migration, the group of cells 
retains their cell to cell interactions as well as collective polarity. Wound healing 
assay or scratch assay is a 2D in vitro technique used to study collective cell migra-
tion. In this assay, a scratch is made on the confluent cell monolayer resulting in the 
formation of a gap or wound which is monitored by taking pictures of the migrating 
cells at regular intervals of time. These pictures are then used to measure the speed 
of wound closure and thus quantify migration. Live-cell imaging using Time-lapse 
microscopy can be used for a more detailed study of cell migration behavior [20]. In 
order to reduce the effect of cell proliferation on gap filling, the readings are taken 
for a time period of 24 hours but this may vary depending on the cell line.
Another assay involving the response of single cells to various chemo-attractants 
is the transwell assay or the Boyden Chamber assay. This assay can be used for 
both adherent and non-adherent cells wherein the cells are placed in a serum-free 
medium on one side of a porous membrane and analyzed on the basis of the cell’s 
ability to migrate through the pores to the other side. Cell migration can be quanti-
fied by counting the cells that have traversed through the membrane towards the 
higher concentration of chemoattractant [21]. A drawback of this assay is visual-
izing the cells and their morphology while migrating through pores due to the 
transitive state of cells [22].
2.3 In vitro tumorigenicity assay
Cancer is one of the most frightful diseases in both developing and developed 
countries and imparts a major health burden to the society. Tumorigenicity is the 
tendency of the cultured cells to form tumors. The two common in vitro tumori-
genicity assays are - Colony-forming assay and Tumorsphere assay. The colony-
forming assay is also referred to as clonogenic assay that analyzes the potentiality of 
a single cell to undergo a clonal expansion to form a colony composed of a minimum 
of 50 cells [23]. This assay is usually used to distinguish there productive viability 
of untreated cells from the cells that are treated with ionizing radiation or cytotoxic 
agents. It is also used to study the stemness and the clonogenicity of stem cells [24].
Colony forming assay is performed using the soft agar method. The basic steps 
involved in this assay are treating the cell monolayer in the flask, seeding the 
required number of cells on the agar and incubate for 1–3 weeks, fixing and staining 
the colonies and finally observing the colonies under the stereomicroscope [23]. 
Another in vitro tumorigenicity assay is tumorsphere assay which analyzes the 
potential of cancer stem cells (CSCs), a major cause of tumor initiation, progres-
sion, and recurrence after treatment. This assay is carried out under non-adherent 
conditions and serum-free medium supplied with growth factors of choice lead-
ing to the proliferation of CSCs and formation of spheres whereas the non-CSCs 
undergo apoptosis due to loss of adherence and abundant nutrients [25].
2.4 Cell invasion assay
Cell migration is an important process in biology where the cells changes and 
reaches their destination within a proper environment, in order to execute their 
respective function. It is a normal physiological process that takes place in nearly 
all forms of organisms. However, changes or deregulation of any kind in the pat-
tern of cell migration or invasion are an indication of pathological conditions 
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including inflammatory diseases and cancer metastasis, with the latter being the 
most explored one [21]. There are various biological methods that are commonly 
employed in the scientific community to study the above-mentioned events in 
depth namely, the cell culture wound-healing assay, the transwell migration, and 
invasion assay, individual cell-tracking assay, and spreading assay. These assays aim 
to provide relevant information pertaining to the pattern of cell migration or its 
response to chemoattractant(s).
2.4.1 The cell culture wound-closure assay
It is the simplest of all methods in determining the migration of whole-cell 
masses altogether. Going further in detail, it can be used to interpret individual 
cell’s morphological characteristics and phenotypes during migration. Measuring 
the closed distance compared to the control over regular intervals of time shows 
specific migration changes or phenotype that was unknown in the past [26].
2.4.2 The transwell migration and invasion assay
The transwell migration and invasion assay are used to determine the capabil-
ity of single cells to respond to various chemoattractant(s) including chemokines, 
growth factors, lipids, or nucleotides. It also contributes to assessing differential cell 
migration due to the over-expression of a receptor. It also identifies and character-
izes the key regulators participating in cell migration [26].
2.4.3 Individual cell-tracking assay or single-cell tracking assay
Conducting single-cell tracking and its live imaging under appropriate condi-
tions adds to the overall advantage of cell migration assay. The software includes a 
time-lapse video-microscopy protocol comprising of post-processing tracks of the 
cell populations with single-cell resolution. It greatly helps to understand the cell 
biology and lineage progression of distinct cell populations [27].
2.4.4 Cell spreading assay
In this type of assay, the spreading process of individual cells is seen and 
recorded with the help of Differential Interference Contrast microscopy (DIC). The 
spreading state is recorded every 5 seconds with a Charge-Coupled Device (CCD) of 
the camera, producing high-quality grayscale images. The process of taking images 
could extend to several hours [28].
2.5 Hybridoma technology and monoclonal antibodies
Antibodies, one of the major elements of the immune system are the glyco-
proteins produced by the immunoglobulins; B-cells provide protection against 
invading pathogens. The antibodies are highly specific and selective, thus have 
been used as an extraordinary tool in bioengineering and biomedical research for 
many years. The antibodies are majorly classified into two categories, Monoclonal 
Antibodies (mAbs) and Polyclonal Antibodies (pAbs) are based on their origin 
from the lymphocytes. mAbs are produced by only B lymphocyte or B cells and 
are monospecific. Due to this property, they possess high specificity and affinity 
towards a single epitope of an antigen whereas pAbs are produced by different 
B-cells and possess different affinities for multiple epitopes of a specific antigen. 
Since mAbs are highly specific, they are produced on a large scale through culturing 
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of antibodies-producing cells widely known as ‘Hybridomas’, which are commonly 
derived from mice, and the method is known as ‘Hybridoma Technology [29].
Hybridoma technology was discovered and developed by two eminent scientists, 
Georges Kohler and Cesar Milstein in 1975 and is considered to be one of the biggest 
breakthroughs. It has proved to be a robust, effective, and successful methodology 
employed in the field of biotechnology and biomedical research that solely deals 
with mAb isolation. The B cells go through the antibody maturation process in the 
germinal centers of secondary lymphoid tissues (for example, lymph nodes, spleen, 
tonsils, and Peyer’s patches). Upon proliferation, certain mutations are experienced 
by the B cells, specifically in the genes encoding the variable region of the antibod-
ies that helps in the selection for high-affinity tight binding to the corresponding 
antigen. The overall resulting antibodies by B cells consist of a natural pairing of the 
light chain and variable heavy chain genes with constant region genes. This region 
contains Class Switch Recombination (CSR) differentiates from the hybridoma 
technology in which CSR is absent [29].
Following are the steps employed for the production of monoclonal antibody by 
hybridoma technology.
2.5.1 Isolation of antibody-producing B lymphocyte
The mouse/mice is/are immunized every 2–3 weeks with red blood cells taken 
from sheep in order to produce the B cells. These antibodies are isolated from the 
spleen cells of mice.
2.5.2 Screening of mouse for production of antibody
After the process of immunization, the blood samples are taken from the 
mouse to determine the serum antibody titer. When the titer reaches the opti-
mal level, the mouse is boosted by injecting antigen 3 days prior to fusion with 
myeloma cells [30].
2.5.3 Fusion of B cells with myeloma cells
Fusion of isolated spleen cells (limited life span) with tumor lymphocytes 
(immortal) with the help of PEG (Polyethylene Glycol) leads to the development of 
hybridomas with an unlimited life span.
2.5.4 Culturing of hybridomas
Hybridomas are grown in a selective medium containing Hypoxanthine, 
Aminopterin and Thymidine (HAT). Aminopterin present in the media blocks 
pathway for nucleotide synthesis, making the cells dependent on the alternative 
pathway which is not evident in myeloma cells.
2.5.5 Screening and selection of the desired colony
The cells are screened and chosen or selected for production of antibodies with the 
desired specificity.
2.5.6 Culturing of the selected hybridoma cells on large scale
The cells are cultured and used for the production of large quantities of anti-
bodies [31].
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2.5.7 Storage for future use
The cells are frozen and stored for future use in therapeutics.
2.6 Gene therapy
Gene, the fundamental biological unit of heredity that constitutes an ordered 
sequence of nucleotides present in chromosomes. The functional aspect of a gene 
is to encode a protein or RNA molecule inherited from parents such as texture and 
color of the hair and eyes. Any kind of alterations/mutations in a gene sequence 
can lead to abnormal functionality of the genes. Gene therapy is a modern type of 
experimental technique in the medical field which involves rectifying the non-
functional or malfunctioning of genes by replacing them with healthy and func-
tional genes. Several approaches have been implemented by researchers in terms 
of correcting a mutated gene with a healthy copy of the gene or by inactivating the 
mutated gene causing disease. It has been widely studied for various diseases such 
as immune deficiency, blood disorders, eye problems, metabolic disorders, regen-
eration of nerve cells, and cancer [32]. The first case of gene therapy was discovered 
in the 1990s whereby a functional Adenosine Deaminase (ADA) gene was incorpo-
rated in the white blood cells of the patient, replacing the non-functional ADA [33]. 
This application led to interesting results with the immune systems and hence, was 
considered the most reliable technique.
There are two main methods for gene therapy such as- Ex-vivo gene therapy and 
In-vivo gene therapy. The former is the transfer of genes into patient cells outside the 
body and the latter one is the transfer of genes directly to cells inside the body. To 
carry this, several techniques are used like- direct or liposome-mediated injection of 
DNA, calcium phosphate transfection, electroporation, dendrimers, hybrid meth-
ods, retrovirus, and other viral vectors. Clinical conditions on which gene therapy 
has been applied are as follows:
2.6.1 Parkinson’s disease (PD)
The strategy of gene therapy has been applied to this disease in order to improve 
the advanced symptoms of PD. Gene therapy was applied to transfer ‘Glutamic Acid 
Decarboxylase (GAD), a chemical produced by a gene into the basal ganglia. GAD 
showed an increased amount of a neurotransmitter called as Gamma-Aminobutyric 
Acid (GABA), responsible for inhibiting brain signals and decreasing activity in 
the nervous system Decreased GABA activity leads to certain brain-related disor-
ders [34].
2.6.2 Alzheimer’s disease (AD)
AD and other frontotemporal dementias (FTDs) are caused by the accumulation 
of amyloid-β peptide (Aβ) and protein tau in the brain. It is characterized by having 
memory loss, difficulty in learning and communicating along with the inability to 
organize things. The use of recombinant Adeno-Associated Viruses (rAAVs) has 
provided new ways for studying AD and other related neurological disorders [35]. 
Such strategies or approaches have added novel dimensions to medical treatments.
2.6.3 Cystic fibrosis
Cystic fibrosis is a disease known to affect the lungs primarily. Its symptoms include 
inflammation, airway obstruction leading to respiratory tract infection and deformity. 
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Insertion of the Cystic Fibrosis Transmembrane Regulator (CFTR) gene directly into 
the epithelium cells of the respiratory tract bear the capability to lessen the symptoms 
but not totally cure the disease in patients suffering from cystic fibrosis [36].
2.7 Cell therapy
Cell-based therapy is one of the most important and well-known forms of all 
treatments in the fields of modern science & medicine. It is not only a curative 
option for treating deadly or threatening diseases but is also making ‘Regenerative 
Medicine’ the most vital technique in health care with the specific goal of replacing 
diseased cells, tissues or organs and thereby restoring their normal function(s) [4]. 
Over the years, there has been a gush of interests and work done in understanding 
the potential of stem cells. They are the cells found naturally in the living bodies, 
characterized by two defining properties of eternal self-renewal and the propensity 
to differentiate into an adult cell type. There are three main types of stem cells: 
Totipotent (a cell developing into a healthy organism independent of the permis-
sive environment), Pluripotent (a cell developing into any type of adult cell) and 
Multipotent (a cell developing into a limited type of cell) [37].
Following is the account of different stem cells used for the treatment of various 
diseases:-
2.7.1 Pluripotent stem cells
Reportedly, pluripotent cells have been used successfully to treat animals per 
se. Animals diagnosed with diabetes are incorporated with cells containing insulin 
responsive to glucose levels. Additionally, the treatment of the animals suffering 
from acute spinal cord injury and visual impairment is performed with myelinated 
neurons and retinal epithelial cells, respectively. Researchers are still conduct-
ing studies with the use of pluripotent stem cells to cure several disorders such as 
Parkinson’s disease, muscular dystrophy and heart failure.
2.7.2 Induced pluripotent stem cells
The stem cells created artificially from normal adult somatic cells through co-
expression of genes and factors are known as Induced Pluripotent Stem Cells (iPSCs). 
These are important for maintaining the characteristic properties of Embryonic Stem 
(ES) cells. Some reports have stated the successful use of iPSCs in conditions like 
Parkinson’s disease, spinal muscular atrophy, cardiac diseases, blood disorders, diabe-
tes, amyotrophic lateral sclerosis, Huntington’s disease, and familial dysautonomia.
2.7.3 Multipotent stem cells
The multipotent stem cells derived from bone marrow (Hematopoietic stem 
cells) have been used in the 1960s to treat cancer conditions like leukemia, myeloma 
and lymphoma. Mesenchymal stem cells with the capability of forming whole joints 
in mouse models have been used regenerating bone and cartilages form. Curing 
heart ailments are still under clinical trial.
3. Applications of 3D cultures in vitro
Spurred by the recent advent in cell culture technologies, three-dimensional 
(3D) cell culture is paving the way in promoting tissue organization and cell 
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differentiation by triggering tissue-based diseased microenvironment. An ideal 
3D cell culture system generally composed of tightly bound tissues that involve 
cell–cell fluent interaction almost mimicking the extracellular matrix (ECM) that 
is highly dynamic and includes scaffolds of cells in a fluid that enhances them 
to differentiate (Table 1). The key parameter of a 3D culture environment is the 
ability to organize the spatial arrangement of cells with other surrounding cells 
along with physical constraints [8]. This significant approach has gardened great 
focus on understanding complex cellular biology and their responses by validating 
mammalian tissue studies via linking the gap between in vitro and in vivo environ-
ments. The two-dimensional (2D) cell cultures lack several features that 3D cultures 
impart such as tissue-specific architecture and complex cellular interactions that 
make them poor models for complex diseases. Based on the process of preparation, 
3D techniques are categorized into (i) scaffold-based, (ii) scaffold-free culture 
systems. Scaffold-based technique efficiently is more responsive towards cell-to-
ECM connection because of their potentiality of mimicking ECM whilst scaffold-
free technique persuades physiological and cellular gradients. Scaffold or matrix is 
designed according to the tissue of interest, higher is the complexity of the scaffold, 




• High reproducibility • Expensive to prepare
• Therapeutic inhibition to drug exposure can 
be easily evaluated through image analysis
• Optimization protocols for each cell 
line is required
• Constant perfusion • Difficult light matter interactions for 
large spheroids
• Lower consumption of reagents • Differences in spheroids’ diameters,
• Control of shear stress and pressure on cells • Low-throughput
• Capable of imbibing large amount of water or 
biological fluid
• Labour intensity
Hydrogels • Ease of maintenance • Low mechanical strength
• Amenable of controlling the micro-tissue size 
and large amount of micro-tissues per plate
• Difficult to handle
• Expensive
Organoids • Amenable to high-throughput screening • Absence of microenvironment
• Long lived organoid production from single 
cells
• Optimization protocols are not 
globally standardized.





• Easily evaluate cell–cell interactions of cancer 
microenvironment
• Microbial contamination
• Provide fluid flow • Static condition
• Easy to handle and quantify
• Relevant mechanical cues
Organ-on-
a-chip
• Enable stable co-culture of living human cells • Architectural complexity of devel-
oping human tissues and organs
• Good control over microenvironment • Difficulty in standardization and 
scale-up
Table 1. 
Merits and demerits of different 3D cell culture techniques.
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scaffolds manufactured are polymeric hard material-based support, microfluidic-
based assembly, hydrophilic glass fiber, and organoids. In contrast, scaffold-free 
systems form cellular aggregates called spheroids that have evolved with improve-
ment in their techniques such as magnetic levitation, liquid overlay (low adhesion 
plates), hanging drop microplates, and spheroid microplates yet the demand for 3D 
scaffolds preferentially increased due to their immense property of modulating the 
behavior of cultured cells according to the matrix in which they are cultured.
3.1 3D Spheroids
3Dspheroids or multi-cellular aggregates are spherical micro-sized cellular 
constructs that are produced from numerous gamuts of cell types, originally from 
scaffold-free systems. The most characteristic features of 3D spheroids are the 
ability to recapitulate a cell’s typical physiological behavior, cellular heterogene-
ity, gene expression, cell–cell signaling, and structural architecture with respect 
to cell–cell contact [10]. Various types of 3Dspheroids include embryonic bodies, 
tumor spheroids (spheres of different tumorcells), hepatospheres (spheres of 
hepatic cells), neurospheres (spheres of different cell types of the central nervous 
system (CNS)) and mammospheres (spheres of mammary glands) [38]. An ideal 
3D spheroid constitute ECM components such as proteoglycans, laminin, collagen, 
fibronectin, tenascin, and glycosaminoglycans [39] which tightens the spheroid 
density with close ECM-cell and cell–cell anchors eventually increase interstitial 
fluid pressure (IFP). Depending on the primary amount of cells seeded, the size of 
spheroid increases with an elevation in cell number, oxygen, and nutrient gradients 
equivalent to the tissue of interest [5]. Alongside, the different techniques enabling 
spheroid cultures are illustrated further.
Hanging drop technique is a non-scaffold method wherein a drop of media 
containing cells are suspended inversely on the lid of the culture dish (bottom-less 
and open) such that there is no surface provided for the cells and tend to hang. This 
attempt forms a cluster called spheroid at the tip of the droplet when cultured for a 
longer period [40]. Spheroids formed through hanging drop cultures have fetched 
considerable stance in cell culture technology with 100% reproducibility owing 
to ubiquitous applications in cancer research [41], toxicity testing in hepatocytes 
[42], and constructing cardiac spheroids [43]. Another method involves the use of 
a liquid overlay that eases the formation of aggregates and commercially produced 
as low adhesion plates. These spheroid microplates contain either hydrophilic or 
hydrophobic coating with V-shaped bottom and allow mild attachment to the sur-
face such that the cells tend to self-aggregate and form spheroid. Unlike the hanging 
drop technique, low adhesion plates generate one spheroid per plate that signifies 
its importance for multicellular culture. This ensures a medium-throughput screen-
ing that requires no modification in spheroid formation [44]. Spheroids can also 
be cultured with the use of magnetic nanoparticles with the application of the 
magnetic field. The process is called magnetic cell levitation that is highly applied 
to produce spheroids of mesenchymal stem cells and tissue engineering [45, 46]. 
An in vivo study showed that human glioblastoma cells levitated by a magnetic 
approach closely mimicked the protein expression of human glioblastoma tumor 
xenografts [47].
3.2 Organoids
Organoids refer to the primary cultures derived from cell aggregates through in 
vitro process that is grown in 3D gels containing ECM to produce organ-like buds 
with the application of either physical support (cell adherence) or biochemical 
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cues (signaling pathway modulation). Various types of cells such as embryonic, 
adult, primary, and stem cells are utilized for the development of organoids. Based 
on organ-like structures formed, organoids are classified into tissue and stem cell 
organoids. The application of organoids has helped in producing numerous in vitro 
organoids such as rectal [48], gastric [49], lung [50], liver [51], pancreas [52], retina 
[53], thyroid [54], kidney [55] and intestine [56] that had successfully recapitulated 
the structural and functional motif of real organs. 3D organoids are extensively 
used by researchers to decipher the toxicity analysis, examine the genetic patholo-
gies and investigate the local immune responses to infections. In addition to this, 
current reports have suggested the promiscuous application of organoids in plat-
forms like transcriptomics and proteomics technologies. One such example illus-
trates the interaction study between Zika virus and Toll-like receptor 3 is performed 
by the generation of cerebral organoids from embryonic stem cells [57]. They have 
been also used as models for distinct genetic diseases. For instance, a study applied 
the rectal organoid model of cystic fibrosis for the investigation of the potency of 
transmembrane regulator-modulating compounds [48]. Besides, the tubular organ-
oids model of polycystic kidney disease was also used to unravel the cause for cyst 
formation [55]. Apart from this, organoids have been an excellent source of models 
to understand the depth of neurodegenerative diseases viz.; Alzheimer, Parkinson’s, 
HIV, diabetes, or cancer.
3.3 Cancer co-culture models
Cancer cell lines have emerged as an eminent tool for comprehending complex 
physiology of cancers. The cell cultures have eased the outlook in preclinical 
research to understand the process of disease, morphological changes occurring in 
tissue, gene function, cell biology and tissue engineering [58]. They have evolved 
with immense features of offering homogenous samples without any sort of 
modification and variations. However, a big leap was noted when monolayer cell 
cultures (2D) obtained from solid tumors were incapable of mimicking the struc-
tural elements of tumor microenvironment. Thusly, 3D cancer cell culture models 
have placed an enduring platform recently whereby ECM in 3D construct is same as 
that of original cell culture and imparted knowledge of predicting tumor response 
to treatment [59]. The application of 3D cell culture models of tumors have ought 
to manifest typical properties of tumor microenvironment such as gene and protein 
expressions, morphology, angiogenesis, malignancy and invasiveness. From this 
standpoint, 3D tumor cell culture models scintillate anticancer therapeutics and 
cancer drug discovery. To date, a vast content of literature owes the significance of 
these 3D co-cultures models in varying applications. In a study, tumor-associated 
macrophages (TAM) or cancer-associated fibroblasts (CAF) and gelatin hydrogel 
microspheres (GM) have been applied to produce cancer co-culture models from 
different cancer cells including HepG2 (liver), MCF-7 (breast) and WA-hT (lung) 
in order to inspect sustained release of drugs. They induced metastatic proteins 
involved in epithelial-mesenchymal transition (EMT) with transforming growth 
factor-β1 (TGF-β1) and reported elevation in N-cadherin and Vimentin proteins 
with deceleration in E-cadherin protein [58]. Recently, cancer co-culture models 
evinced interest in numerous approaches such as 3D breast cancer co-culture 
models obtained from MCF-7, MRC-5 and MDA-MB-231 tumor cells were used in 
investigating radiation-induced fibrosis [59], tumor-associated fibroblast differen-
tiation [60] and development of immunotherapies [61], 3D lung cancer co-culture 
models derived lung squamous carcinoma and Non-Small Cell Lung Cancer Cells 
(NSCLC)fromTUM622, A549 and Colo699 tumor cells were utilized to explore 
tumor-stroma interactions [62, 63], 3D renal cancer co-culture models formed from 
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Caki 1 (skin metastasis derived) and ACHN (pleural effusion derived) were sought 
for determining the efficacy of produced 3D models in stem cell physiology research 
and drug toxicity screening [64]. 3D colon cancer co-culture models acquired from 
LS 174 T, HCT 116, Colo205, MCF7, SW480, SW620, CCD-18Co, Caco-2, HT-29, 
and H446 have also been used to explore tumor-stroma interactions [65].
3.4 Tissue co-culture models
In vitro tissue models with the use of co-culture cells have emphasized greater 
applications to represent varying mechanisms of human body which is a daunting 
task. These models have served a vital role over several animal models that once 
were used to examine human physiology and pathophysiology. The major limita-
tion of animal models was the failure of mimicking true human facets and their 
ethical constraints. This led to fetch insights into development of tissue models as a 
research tool from co-cultures such that the created models would possibly reca-
pitulate the natural microenvironment of cells and examine the pathophysiological 
bases of diseases. Distinct in vitro 3D tissue models have been achieved with the 
approach of tissue engineering comprising human characteristics with increased 
complexity as compared to the 2D monolayers. Some of the examples of 3D models 
constructed from tissue co-cultures include kidney [66], neuro-glia [67], lung 
[68], liver [69], ovary [70] and intestine [71] that have potentially predicted and 
represented physiological responses of the original culture of cells. Most probably, 
primary cells are used as they possess feasible in vivo features of not being immor-
tal, incapable of getting transformed and consist of limited survival time in culture. 
Pertaining to these advantages, they have been applied to develop models that 
would combat various disease and physiological studies. Reportedly, tissue models 
have been revolutionized in terms of investigating multiple changes in real-time 
processes. A pulmonary endothelium model was constructed to investigate massive 
inflammation in patients with acute respiratory disease syndrome (ARDS). The 
authors performed this study using lavage samples of the patients for determining 
the etiology of ARDS that took place during the process of disease [72]. In addition, 
endothelial cells have also played a key role in constructing 3D tissue models with 
their fascinating physiological roles. For instance, in vitro gastrointestinal epithelial 
cell cultures derived from adult murine colon allowed the authors to analyze epi-
thelial cell–cell interactions, microbiological infections and cellular signaling [73]. 
Another instance showed the potential of hepatocyte tissue cultures in maintaining 
the cancer cell hierarchy in human hepatocellular carcinoma [74].
3.5 Organ-on-a-chip
Organ-on-a-chip is a biomimetic system that uses fabrication of computerized 
microchips and microfluids consisting of living cells, mimicking the natural environ-
ment of organs from which it is been created. There are several factors that made 
organ chips be listed in “Top Ten Emerging Technologies” in the World Economic 
Forum [75] such as shear force, tissue-boundaries, concentration gradients, tissue–
organ interactions and cell patterning. Organ chips have intensified in the field of 
drug therapeutics for their ability of high throughput screening. Table 2 summarizes 
the recent researches carried out using various organ chips. These organ chips use 
microtechnology that provides nutrients to the cells for their better growth and prolif-
eration. Microfluids are one such component that has been used in various studies for 
efficient treatment in drug sensitivity testing [86]. Talking of this notion, a micro-
fluidic chip was produced in order to monitor and document real-time impedimetric 
biosensor changes. Other organ-on-a-chip models such as blood–brain barrier chips 
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have been developed to represent the in vivo architecture of brain involving micro 
blood vessels by using type 1 collagen hydrogel. Another model entails the signifi-
cance of human-on-a-chip that depicts the normal human physiology in combination 
with single organ chip within a microfluidic system that ultimately forms multi-organ 
chip [87]. One study dealt with an in vitro 3D-tumor-on-a-chip device that illustrated 
its importance in quorum sensing phenomenon in tumor cells activated by salmonella 
[88]. Hence, organ-on-a-chip has been diversified in many scientific platforms due to 
their efficient physiological bio-mimicry.
Organ type Incorporated cell types Organ-specific properties Ref.
Lung Primary lung alveolar 
epithelial cells
• Breathing movements [76, 77]
Primary lung endothelial 
cells
• In vivo functionality array of tiny alveoli
• Human lung parenchyma (lung alveoli 
and ultrathin air–blood barrier)
• Recreates the native viscoelastic 
microenvironment of the cells
Human vascular 
endothelial cells
• Alveolar capillary barrier in the human 
lung
[78]
Human alveolar epithelial 
cells
Skin Peripheral perfusion fluid 
(PPF)
• Franz diffusion cell system [79]
• Drug absorption across the dermal 
barrier
• Microfluidic Diffusion Chamber (MDC)
Liver Hepatic cell lines • Hepatoprotective effect assessment [80]
• Hepatic activity (cell viability, albumin 
synthesis, urea secretion, and cyto-
chrome P450 enzyme activities)




• Human glomerular filtration barrier [81]
• Functions and structure of the 
glomerulus
Human-derived renal 
proximal tubule epithelial 
cells




Heart Cardiomyocytes • Contractile behavior (contraction force, 
frequency, and synchronization) of a 3D 
cardiac tissue construct
• Three-dimensional beating tissue from 
human cardiomyocytes
[83, 84]
Pancreas Human pancreatic beta-
cell line








Animal models used in laboratories have been greatly avoided due to the fact that 
they are costly and require a large number of laborers. This approach was replaced 
by the use of in vitro models wherein despite having several advantages; still, the 
application is constrained due to poor cell-to-cell and cell-to-matrix interactions. In 
vitro culture of cells has been observed to acquire multiple genetic and epigenetic 
variations that eventually make the cells lose their originality. The above-listed 
models comprise their own merits and demerits in respect of cellular response, cel-
lular composition, and structural features. The above-mentioned models consist of 
a few advantages and disadvantages with respect to cellular composition, mimick-
ing the in vivo physiology of original tumor architecture, tumor microenvironment 
(TME) and the response to different exogenous stimuli. Therefore, patient-derived 
cells have come into the picture which is generally a co-culture-based technology 
that is grown in a culture medium supplemented with all sorts of nutrients [89]. 
Different studies have exemplified the use of patient-derived cells as a preclini-
cal model in drug discovery (screening and responses) in several types of cells. 
Patient-derived xenograft (PDX)models are made of minute pieces of tumor tissue 
of the surgical patients, utilized for implantation into an immune-deficient mouse. 
In a study, Fong et al. used PDX models from prostate cancer to investigate tumor-
stromal interactions via the use of a 3D hydrogel system [90]. Likewise, in another 
study, Liu et al. demonstrated the establishment of patient-derived cell cultures 
from colorectal cancer cells of biopsies of cancerous and non-cancerous tissue 
that could grow in in vitro culture indefinitely by recapitulating exactly the same 
phenotypic and genotypic features of the original tissue [91]. Some of the research-
ers have also elaborated patient-derived 3D culture using a scaffold-based organoid 
culture that is prepared to preserve the genomic features of the original tissue [92].
4. Three-dimensional cell culture in drug discovery and development
Drug discovery is a lengthy and time-consuming process that undergoes several 
stages of testing and optimization. This encompasses identification of the target, 
lead discovery, pre-clinical validation, and clinical trials [3]. Due to the constant 
failure of drugs in Phase II and Phase III clinical trials, there has been constant 
pressure on the pharmaceutical industry to seek more novel drugs with lower side 
effects and cost-effectiveness. 3D cell culture has emerged as a significant high-
throughput system that has uplifted the standards of cell culture [93]. Specifically, 
spheroids are considered the most reliable model for testing drugs in various dis-
eases because of their capability of resembling the natural environment of original 
tissue [93]. The spatial organization of spheroids in different layers of cells leads to 
cellular death by forming reactive oxygen species [94]. In the case of investigating 
the effect in 3D spheroids, fluorescence microscopy plays a key role in determin-
ing pharmaceutical dispersion within spheroids (eg-doxorubicin and epirubicin) 
[95]. The capital importance of any drug testing involves cell-based assays that are 
efficient enough and easily reproducible compared to expensive animal models. 
Cell-based assays have shaped the physiological relevance of 2D cultures [96]. 
While the reaction may vary from technique to technique such as cell viability, 
proliferation, signaling and migration and drug to drug for achieving better sensi-
tivity. It is now broadly accepted that compared to 2D cultures, 3D models serve the 
resemblance of the natural environment of original tissue efficiently and differently 
in 3D environments. Research has nested stance on novel 3D culture technologies 
that impart functional basis of tissues such as spheroids and organoids [97]. A study 
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used 3D hydrogel-based model for the determination of drug sensitivity in HepG2 
cell lines by comparing cytotoxicity effect with cytotoxicity (CT50) and lethal dose 
(LD50) values [98]. Organoid 3D models also aid as a resourceful tool for model-
ing neurodevelopmental disorders [98]. Microfluidic chips have also been utilized 
in drug sensitivity testing whereby a study elaborated its efficacy in lung cancer 
which was in combination with stromal cell lines [98]. Evaluation of absorption, 
distribution, metabolism, excretion, and toxicity (ADMET) of the drug is primarily 
examined in in vitro cell culture experiments. 3D cell cultures have fostered drug 
pharmacokinetics in several studies with the implementation of various types of 
cell culture models.
5. Cell based manufacturing of therapeutic proteins
Therapeutic proteins production using human cell lines has greatly influenced 
different medical areas including biopharmaceutical research and vaccine produc-
tion. Mammalian cell lines prove futile in protein production due to their likelihood 
of possessing post-translational modifications (PTMs) achieved from recombinant 
proteins that are in accordance with the endogenous human proteins. These cell lines 
show exquisite specificity to produce similar proteins to those in humans naturally 
synthesized, an advantage over mammalian expression systems [99]. One of the most 
routinely and high yields of proteins production is performed by using cell-based 
expression systems such as Chinese hamster ovary (CHO) a cell line that constitutes 
major advances such as accomplishment of gene amplification, specific productivity, 
better selection strategies, and devising greater expression units and advanced hosts. 
CHO cells have established their safety profile for 20 years from the production of 
its first recombinant biotherapeutic protein in 1986 [100]. Other human cell lines 
such as BHK-21 cells are used for the generation of few coagulation factors such as 
factor VIII [101]. There are two vital human cell lines namely, HEK293 and HT-1080 
that are used to manufacture licensed products of human PTMs. The advancement 
in protein-based drug development and technologies has driven more towards the 
therapeutic proteins market that comprises of sales of these therapeutic proteins. The 
methods that are involved in the production of these proteins are pegylation, glycoen-
gineering, albumin fusion, Fc-fusion, product purity, targeting, and functionality of 
therapeutic protein drugs. Few examples of therapeutic protein drugs which has been 
produced using protein engineering technologies and approved by the Food and Drug 
Administration (FDA) from the past five years are imiglucerase, Belimumab, alfa, 
coagulation factor IX recombinant human and albiglutide [102]. A French pharma-
ceutical company named Sanofi accomplished a great achievement of strengthening 
its R&D strategy with the best proprietary therapeutic proteins production pharma-
ceutical company, Ablynx, for a nanobody technology platform.
6. Conclusion
In particular, a plethora of research studies have shed light on the fact that in spite 
of the availability of advanced organ-on-chip technologies and bioengineered 3D mod-
els, the application is limited by drug companies due to their relatively novel approach 
which is more likely requires to undergo further validation and characterization. 
Moreover, 3D cell culture models with high-throughput screening in combination with 
high-content leads to the identification of clinically relevant compounds. However, 
still many difficulties are being faced as 3D cell cultures do not meet certain criteria in 
the drug discovery process with regard to size, morphology, complexity, and protocol 
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for assaying. It requires ample standardization and optimization to extract successful 
specific phenotypes for drug screening. Thus, there are few 3D models that are con-
strained for their restricted access due to limited permeability. Following the advances 
in protein therapeutics, more improvements in generating sophisticated therapeutic 
protein products will be developed for better futuristic research.
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